NIH-funded research R21 grant

A smarter supplement plan to help prevent birth defects in pregnancies affected by diabetes

Official title: Beyond Folate - a Supplementation Strategy to Prevent Neural Tube Defects

Funded at Lsu Pennington Biomedical Research Ctr · NIH-11391049 · Data updated 2026-11-12

A small NIH-funded project tests whether providing specific downstream nutrients to embryos can prevent birth defects in pregnancies where the mother has diabetes.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionLsu Pennington Biomedical Research Ctr
NIH-funded
Lab location1 site (Baton Rouge, United States)
Project startAugust 11, 2025
Project endJuly 31, 2027
Funding year2026
Award (this year)$225,000
NIH project number5R21HD115906-02
Project IDNIH-11391049 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are pregnant individuals or those planning pregnancy with diabetes who receive medical supervision and meet standard obstetric criteria.

Less likely to help

The approach may not benefit pregnancies without diabetes or where the fetus has unrelated developmental risks.

What this research studies

This project explores how diabetes during pregnancy can disrupt embryo energy and nutrient balance, potentially leading to defects like heart and neural tube problems. Researchers will study how supplying downstream metabolites of glucose might normalize embryonic gene pathways during critical development. It builds on prior data showing that a simple glucose boost can reverse some stress signals, and tests a refined approach that would not increase glucose itself. The study is exploratory and designed to guide safer nutrient-based strategies for pregnancies affected by diabetes.

Why it matters

Potential benefit: If successful, this work could inform new nutritional approaches to reduce birth defects in diabetic pregnancies.

How similar studies have gone: Previous work suggests metabolic pathways can be modulated to reduce developmental stress, but this exact glucose-downstream strategy is exploratory and not yet proven in humans.

Where this research is happening

  • Lsu Pennington Biomedical Research Ctr
    Baton Rouge, United States
    Active

Researchers

  • Principal investigator: Salbaum, Johannes Michael — Lsu Pennington Biomedical Research Ctr
  • Study coordinator: Salbaum, Johannes Michael

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.